Call for applications! Research funding opportunities now open

Intramural Research Grant Program

One of the Centre for Innovation’s flagship competitive research grants, the Intramural Research Grant Program supports projects that will generate knowledge and lead to new discoveries that will improve the safety and efficacy of blood products and the blood system in general. A key focus of this program is to encourage collaborative research and to build strong research teams that can address the needs of Canadian Blood Services.

Through the IRGP, 20 projects are currently supported, exploring a wide range of critical topics from improving stem cell therapeutics and their manufacturing processes, to understanding the impact of transfusion and blood product manufacturing on patient outcomes, to finding novel replacements for IVIg.

Learn more in our funded research projects database (select “Intramural Research Grant Program” under Programs).

The 2021 competition is open to anyone affiliated with a Canadian academic program as a faculty member, but each project team must include at least two investigators, at least one of whom must be affiliated with Canadian Blood Services as a scientist, adjunct scientist, or medical director/officer/consultant.

Research priorities for the 2021 Intramural Research Grant Program are:

• Promoting appropriate blood product utilization;

• Ensuring an adequate blood product supply;

• Minimizing the adverse effects of blood product transfusion;

• Optimizing blood product quality;

• Replacing or improving blood products through new therapies or technologies.

Successful projects will be supported up to a maximum of $400,000 over two years.

The Intramural Research Grant Program has a two-phase application process. First, applicants must register for the Program by February 26, 2021. Eligible applicants who have registered will then be invited to submit a full grant application, which will be due by April 23, 2021.

For more information and links to the registration and application forms, please go here.

Kenneth J. Fyke Award Program

The Kenneth J. Fyke Award program supports health services and policy research to promote the development of evidence-based Canadian practices and policies in blood transfusion, blood stem cell transplantation, and organ and tissue transplantation for the benefit of Canadian patients. Applicants must be researchers affiliated with a Canadian

academic program related to health services or health policy or transfusion medicine, stem

cell transplantation, or organ/tissue donation and transplantation medicine as a faculty

member.

Research priorities for the Winter 2021 Kenneth J. Fyke Award are:

• Optimizing utilization of blood, blood products and/or alternatives, or transplantable products (organs and tissues) at a system or patient level;
• Health economics approaches to evaluate the cost-effectiveness of measures in supporting a safe and sustainable transfusion or transplantation system; and
• Fostering pan-Canadian collaboration in health care.

The Winter 2021 Kenneth J. Fyke Award will support one project with up to $100,000 for a period of one year. Applications are due March 19, 2021.

For more information and links to the application form, please go here.

Learn more about current and future Canadian Blood Services’ research funding opportunities here.

Canadian Blood Services – Driving world-class innovation

Through discovery, development and applied research, Canadian Blood Services drives world-class innovation in blood transfusion, cellular therapy and transplantation—bringing clarity and insight to an increasingly complex healthcare future. Our dedicated research team and extended network of partners engage in exploratory and applied research to create new knowledge, inform and enhance best practices, contribute to the development of new services and technologies, and build capacity through training and collaboration. Find out more about our research impact. 

The opinions reflected in this post are those of the author and do not necessarily reflect the opinions of Canadian Blood Services nor do they reflect the views of Health Canada or any other funding agency.